Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2013 / Article

Research Article | Open Access

Volume 2013 |Article ID 272134 | https://doi.org/10.1155/2013/272134

Vidya Ignatius, Madhusudhanan Narayanan, Venkataraman Subramanian, Balasubramanian Maruthaiveeran Periyasamy, "Antiulcer Activity of Indigenous Plant Operculina turpethum Linn.", Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 272134, 7 pages, 2013. https://doi.org/10.1155/2013/272134

Antiulcer Activity of Indigenous Plant Operculina turpethum Linn.

Academic Editor: José Luis Ríos
Received26 Jul 2012
Revised19 Dec 2012
Accepted21 Dec 2012
Published11 Feb 2013


In the Indian traditional system of medicine Operculina turpethum is commonly used to treat various ailments including peptic ulcer, inflammation, and pain. Ulcer preventive and ulcer protective activities of HAOP and MOP stem bark extracts of Operculina turpethum (100 mg/kg, b.w., orally) were evaluated employing aspirin + pylorus ligation (APL) model in experimental rats. The results suggested that both extracts (HAOP and MOP) possess enhanced ulcer preventive and protective activities when compared with the standard drug ranitidine. HAOP showed more pronounced effect when compared to MOP. Further the result of the histopathological and biochemical studies also confirms potent ulcer preventive and protective nature of a extracts in a similar manner.

1. Introduction

Peptic ulcer is one of the common disorders of gastrointestinal tract, which occur due to an imbalance between the offensive (gastric acid secretion) and defensive (gastric mucosal integrity) factors [1]. Stress, smoking, nutritional deficiencies, and frequent intake of nonsteroidal-antiinflammatory drugs (NSAIDs) develop the peptic ulcer prevalence in the world [2]. It is a known fact that well-targeted therapeutic approaches are needed for the treatment of peptic ulcer disease.

A wide range of drug is currently available for treatment of gastric ulcer which includes proton pump inhibitors, H2-blockers, antiacids, and anticholinergics. The most common adverse effects of these drugs are hypergastrinemia, hypersensitivity, gynecomastia, impotence, arrhythmia, and blood dyscrasias such as thrombocytopenia and enteric infections (Clostridium difficile) [3]. These effects are the rationale for the development of new antiulcer drugs. For this reason, the hunt is still on to discover a natural medicine having antiulcerogenic properties.

A number of medicinal plants have been used for thousands of years in the traditional system of medicine (Ayurveda) to treat various diseases like peptic ulcer, cancer, diabetes, arthritis, hepatitis, acute and chronic inflammations, neurodegenerative diseases, and so forth [4].

Operculina turpethum belongs to the family Convolvuceacea [5, 6]. It is popularly known as “transparent wood rose” and widely used for the treatment of ulcers, tumors, neurological disorders, constipation, dysmenorrhea, and inflammation [79]. It is one of the components of Ayurvedic formulations such as Trivrit choornam, Trivritadi choornam, and Avipattikar ghritam.

It is a perennial climber and it exudates a milky juice. Stem is very long, twining and much twisted, angled, and winged. The roots are long, slender, fleshy, and much branched. The black variety of root is powerful drastic, bitter with a sharp sweet taste while white variety is moderately cathartic and red variety is sweetish acrid [5, 6].

The plant root contains a glycoside resin, which is mainly concentrated in the root bark. It contains glycosides (Scopoletin, turpethinic acid A, B, C, D, and E). Stem of the plant contains triterpenes (betulinic acid, betulin, and lupeol) and sitosterol [5, 10, 11]. There are a few reports on the cooccurrence of both calystegines and swainsonine, a polyhydroxylated indolizidine alkaloid well-known from certain convolvulaceous species [12]. The plant possesses anticancer, antiproliferative [13], antimicrobial [14], antidiabetic [15], anti-inflammatory [16], and antihepatotoxic [17, 18] activities.

Though the Plant has been extensively for various diseases including treatment of ulcers. Hence, an attempt has been made to screen the ulcer preventive and protective activity of the extracts of the stem bark of Operculina turpethum in animal model.

2. Materials and Methods

2.1. Plant Material

The dry stem of Operculina turpethum was purchased from the Indian Medical Practitioners Co-operative Society (IMCOPS) Chennai, Tamil Nadu, India which was authenticated by Dr. S. Jayaraman, Director at the Plant Anatomy Research Center, Chennai, Tamil Nadu, and a voucher specimen has been deposited at the herbarium unit of the Department of Pharmacology and Environmental Toxicology, University of Madras, Taramani, Chennai.

2.2. Preparation of Extracts (Methanolic (MOP) and Hydroalcoholic (HAOP))

Operculina turpethum stem bark was scrapped, chopped, shade dried and coarsely powdered. One portion of the powder was then extracted with methanol using Soxhlet extractor and the other portion was extracted with ethanol-water in the ratio of 1 : 1, being stirred and macerated at room temperature for 10 days. The extracts were dried under reduced pressure using rotary flash evaporator and stored at −20°C. The percentage yields of hydroalcoholic (HAOP) and methanolic extracts are 9% w/w and 6% w/w, respectively.

2.3. Animals

Forty-two male Wistar Albino rats (  g) procured from the Tamil Nadu University of Veterinary and Animal Science were used for the study. The animals kept in polypropylene cages were acclimated to laboratory conditions for one week before starting the experiment (12 h dark : 12 h light cycles; °C) and provided with standardized pellet feed and water ad libitum. Animals that were submitted to oral administration of extracts and standard drugs were fasted for 18 h before the experiments. The experimental protocol was approved by the Institutional Animal Ethical Committee (IAEC NO: 07/042/05) and the study was conducted in accordance with CPCSEA guidelines.

2.4. Aspirin + Pyloric Ligation Induced Ulcer Model
2.4.1. Experimental Setup

The animals were divided into seven groups of six animals each.Group I: PL control animalsGroup II: aspirin + pylorus ligated control animalsGroup III: ranitidine (50 mg/kg/p.o) + pylorus ligated animalsGroup IV: HAOP alone (100 mg/kg/p.o) treated animalsGroup V: HAOP (100 mg/kg/p.o) + aspirin + pylorus ligated animalsGroup VI: MOP alone (100 mg/kg/p.o) treated animalsGroup VII: MOP (100 mg/kg/p.o) + aspirin + pylorus ligated animals.

The methods of the Goel et al. [19] and Shay et al. [20] were followed for the evaluation of preventive and ulcer-protective activities.

The groups III–VII received the assigned drug treatment for 10 days daily. From day 8–10, groups II, III, V, and VII animals received aspirin orally as an aqueous suspension (200 mg/kg) 2 h after administration of the drugs [19]. Animals in all the groups were fasted for 18 h and pylorus ligation was carried out on the 11th day.

Pylorus ligation was carried using light ether anesthesia; the abdomen was opened through a midline incision. Pylorus was exposed and ligated using fine thread around it without disturbing the stomach. Then animals were sutured and returned to their cages, respectively. Four hours after pylorus ligation, the animals were sacrificed by cervical decapitation.

The stomachs were removed and opened along the greater curvature and washed; gastric lesions were observed. The gastric juice collected by a modification of the pylorus ligation technique described by Shay and his colleagues [20, 21] is a valid approach for collection of gastric juice in the rat models. Then the samples were subjected to biochemical analysis; the volume of the supernatant was expressed as mL/100 g body weight [22]. Ulcers were scored and the ulcer index was determined [23]. Total acidity, free acidity, and various biochemical investigations were also carried out, respectively.

2.5. Statistical Analysis

Data are presented as the mean ± standard error (SEM). One-way ANOVA followed by Tukey’s multiple comparison test was used to compare the mean of different groups by using SPSS 7.5 Student version.

3. Results

3.1. Biochemical Findings
3.1.1. Ulcer Index and Percent of Protection

The ulcer index and percent of protection against ulcers in the pylorus ligated model are shown in Tables 1(a) and 1(b). Treatment with MOP and HAOP showed significant protection against ulcers in pretreatment (76.53% and 81.32%) and posttreatment (54.21% and 60.13%) at a dose of 100 mg/kg ( ) when compared with the control animals, respectively. The standard drug, ranitidine, showed significant protective effects against ulcers (65.14%) at a dose of 50 mg/kg when compared with the control groups ( ) in both treatments.


Pretreatment Dose (mg/kg) Ulcer index Protection (%)

Aspirin + pylorus ligated control 4.39 ± 0.04 a*
Ranitidine 50 mg/kg/p.o 1.53 ± 0.02 a*b*65.14
MOP 100 mg/kg/p.o 1.03 ± 0.009 b*c*76.53
HAOP 100 mg/kg/p.o 0.82 ± 0.007 a*b*c*81.32


Posttreatment Dose (mg/kg) Ulcer index Protection (%)

Aspirin + pylorus ligated control 4.39 ± 0.04 a*
Ranitidine 50 mg/kg/p.o 1.53 ± 0.02 a*b*65.14
MOP 100 mg/kg/p.o 2.01 ± 0.02 a*b*c*54.21
HAOP 100 mg/kg/p.o 1.75 ± 0.02 a*b*c*60.13

The following values are expressed as mean ± SEM of 6 animals.
Comparisons were made between.
a: Group I versus II, III, IV, V, VI, and VII.
b: Group II versus III, IV, V, VI, and VII.
c: Group III versus V and VII.
Symbols represent statistical significance: * , # , @ .
3.1.2. Free Acidity, Total Acidity, Total Acid Output and Gastric Volume

Figures 1, 2, and 3 shows the free acidity, total acidity, total acid output, and gastric volume of the experimental groups. Administration of both the extracts and ranitidine showed a significant reduction ( ) in the total acidity, free acidity, total acid output, and gastric volume.

3.1.3. Mucin Activity, Protein, and Total Carbohydrates Protein Ratio

Table 2 and Figures 4 and 5 shows the values of individual carbohydrates like hexose, hexosamine, sialic acid, fucose, total carbohydrates, protein, and total carbohydrates-protein ratio of the gastric juice in experimental groups. HAOP and MOP pre- and posttreatment showed a significant increase ( ) in the defensive mucin secretion of the gastric juice. Moreover protein concentration in gastric juice was significantly decreased with a significant increase in the total carbohydrate : protein ratio (TC : P) in the treated groups.

Groups Hexose ( g/mL) Hexosamine ( g/mL) Sialic acid ( g/mL) Fucose ( g/mL) Total carbohydrates ( g/mL)

Group I 919.00 ± 18.68 243.04 ± 4.94 69.54 ± 0.67 97.77 ± 1.33 1266.06 ± 39.90
Group II 521.70 ± 9.52 a*138.72 ± 2.53 a*28.34 ± 0.27 a*93.62 ± 1.70 723.00 ± 14.69 a*
Group III 719.04 ± 9.82 a*b*166.50 ± 2.27 a*b*37.70 ± 0.36 a*b@99.70 ± 2.02 933.72 ± 18.98 a*b*
Group IV 860.64 ± 8.31 a@ b*c*252.07 ± 2.43 b*c*68.87 ± 0.94 b*c*100.50 ± 0.97 b@1274.20 ± 17.40 b*c*
Group V 736.84 ± 7.11 a*b*200.44 ± 1.93 a*b*c*55.96 ± 0.76 a*b*c*99.97 ± 0.96 b@1109.38 ± 15.15 a*b*c*
Group VI 877.97 ± 11.99 b*c*258.90 ± 2.50 a@ b*c*71.82 ± 3.64 b*c*101.34 ± 1.38 b@1285.27 ± 17.56 b*c*
Group VII 670.14 ± 6.47 a*b*c@187.19 ± 1.80 a*b*c*50.09 ± 0.67 a*b*c*98.83 ± 0.95 1075.39 ± 10.38 a*b*c#

The following values are expressed as mean ± SEM of 6 animals.
Comparisons were made between.
a: Group I versus II, III, IV, V, VI, and VII.
b: Group II versus III, IV, V, VI, and VII.
c: Group III versus V and VII.
Symbols represent statistical significance: * , # , @ .

3.1.4. Macroscopic Examination

Macroscopic sections of stomach reveal the ulcer score and comparative effect of treatment with the extracts HAOP and MOP when compared with group II pylorus ligated animals visually (Figure 6).

3.2. Histopathological Changes

Histopathological examination of stomach mucosa shows that pretreatment with HAOP, MOP and Ranitidine protects the mucosal epithelium from the damage caused by aspirin. In HAOP and MOP treated groups the mucosa was found to be almost normal with mild edema on the lamina propria. Ranitidine treated section shows normal mucosa with no ulcer but with slight congestion (Figure 7 and Table 3).

GroupsHistological observations on stomach mucosa

Group I PL controlUlcerated mucosa showing discontinuity in the lining epithelium with edematous submucosa
Group II aspirin + PL ControlUlcerated mucosa showing hemorrhage and discontinuity in the lining epithelium with exudates in the lumen with submucosal edema
Group III Ranitidine + aspirin + PLNormal mucosa with no ulcer, edema in the submucosa
Group V
HAOP (100 mg/kg/p.o) + aspirin + PLNormal mucosa with, small atrophic glands, no edema, mild muscularis mucosa
Group VII
MOP (100 mg/kg/p.o) + aspirin + PLNormal mucosa with mild hyperplasia and mild edematous submucosa

4. Discussion

Gastric ulcers arise due to various factors [24]. Even though the etiology of gastric ulcers is still debated, it is accepted that ulcers are caused due to net imbalances in mucosal offensive and defensive factors [25].

Common NSAIDS like aspirin cause damage to the gastric mucosa by interfering with prostaglandin synthesis. Furthermore, it results in generation of free radicals, imbalance in gastric secretion, elevated pepsin, protein content, and back diffusion of H+ ions into the gastric mucosa leading to necrosis and ulceration [26, 27]. Wide ranges of remedial drugs including medicinal plants that are used in the treatment of peptic ulcer inhibit the gastric acid secretion and provoke the mucus secretion by reversing the consequence of aspirin. In the present study, pre- and posttreatment with HAOP and MOP extracts attenuated the gastric volume, free acidity, total acidity, total acid output, and ulcer index thus showing the antisecretory property. These results suggest the possible involvement of prostaglandins and/or mucus in the antiulcer activity of the extracts.

Gastric wall mucus, an obligatory component of which is hexosamine, is thought to play an important role as a defensive factor against gastrointestinal damage [28]. The determined gastric wall mucus was used as an indicator for gastric mucus secretion, while mucosal hexosamine content was used as an indicator for gastric wall mucus synthesis [29]. Aspirin + pylorus ligation decreased the concentrations of all the individual carbohydrates and also the carbohydrate-to-protein ratio. Previous findings of Vasudeva et al. [30] and Sanmugapriya and Venkataraman [31] reported a similar decrease in accordance with the present study.

Ulcer induced group II animals showed increase in protein content of the gastric juice indicating gastric mucosal damage due to leakage of plasma proteins [3234]. Both extracts showed decrease in protein levels, which indicates strengthening of the gastric mucosa, thereby restricting the entrance of the plasma proteins into gastric juice. In addition a significant increase in the defensive mucin secretion was quantified in terms of hexose, hexosamine, sialic acid, fucose, and total carbohydrates : protein (TC : P) ratio of the gastric juice [35].

The increased mucus secretion in the extract treated groups may attribute to lessening of stomach wall friction during peristalsis and gastric contraction, improving the buffering of acid and by acting as an effective barrier to back diffusion of hydrogen ions [36]. Moreover, mucus is capable of acting as an antioxidant, and thus can reduce mucosal damage mediated by free radicals [37].

Further, histopathological examination of stomach mucosa shows that pre- and posttreatment with HAOP, MOP, and ranitidine protects the mucosal epithelium from the damage caused in the ulcer model. In HAOP, and MOP treated groups the mucosa was found to be almost normal with mild muscularis mucosa. Ranitidine treated section shows normal mucosa with no ulcer; edema in the submucosa establishes ulcer preventive and protective nature of the plant extracts.

The nonspecific gastroprotective findings of MOP and HAOP may be due to presence of phytoconstituents like triterpenoids (betulinic acid, epibetulinic acid, betulin, and lupeol), steroids (sitosterol), and glycosides (Scopoletin, turpethinic acid A, B, C, D, E) [5, 10, 11]. The mechanism of action of these phytochemicals may be attributed to causing the inhibition of gastric acid secretion or to boosting the mucosal defense mechanism by increasing mucus production, stabilizing the surface epithelial cells or interfering with the PGs synthesis.

Gastric acid secretion is influenced by histamine release, gastrin secretion, and acetylcholine release [38]. H2 blockers like cimetidine, ranitidine, and famotidine exhibit antihistaminic effect thus causing reduction in gastric acidity and secretory volume since they have a five-membered ring structure with a flexible side chain attached to polar uncharged group. Evidently, betulinic acid an active constituent in both the extracts having similar ring structure to H2 blockers may be a reason for the antihistaminic effect, which is responsible for gastroprotective nature [39, 40]. Moreover, betulinic acid, lupeol, betulin, and glycosides [31, 4144] present in the extracts possess potent antioxidant properties by decreasing lipid peroxidation and increasing antioxidant levels.

On the other hand, the presence of flavonoids facilitates the increase in the mucosal prostaglandin levels and inhibition of histamine release thus exhibiting a protective effect of the extracts [45].

It is also reported that saponins is shown to have ulcer protective effect by the formation of protective mucus which shield the mucosa from acid damage by selectively inhibiting prostaglandins. Moreover, tannins precipitate the microproteins thereby forming an impervious protective pellicle over the ulcerated gastric lining resulting in inhibition of toxic substance adsorption and prevent from further proteolytic enzyme degradation [46].

In conclusion, the ulcer preventive and protective activity demonstrated in the present study provides a strong support for the traditional use of this plant in the treatment of gastric and intestinal ulcers.


  1. M. Umamaheswari, K. Asokkumar, R. Rathidevi, A. T. Sivashanmugam, V. Subhadradevi, and T. K. Ravi, “Antiulcer and in vitro antioxidant activities of Jasminum grandiflorum L,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 464–470, 2007. View at: Publisher Site | Google Scholar
  2. C. A. Hiruma-Lima, T. R. Calvo, C. M. Rodrigues, F. D. P. Andrade, W. Vilegas, and A. R. M. S. Brito, “Antiulcerogenic activity of Alchornea castaneaefolia: effects on somatostatin, gastrin and prostaglandin,” Journal of Ethnopharmacology, vol. 104, no. 1-2, pp. 215–224, 2006. View at: Publisher Site | Google Scholar
  3. J. R. Santin, M. Lemos, L. C. K. Júnior, R. Niero, and S. F. de Andrade, “Antiulcer effects of Achyrocline satureoides (Lam.) DC (Asteraceae) (Marcela), a folk medicine plant, in different experimental models,” Journal of Ethnopharmacology, vol. 130, no. 2, pp. 334–339, 2010. View at: Publisher Site | Google Scholar
  4. R. Govindarajan, M. Vijayakumar, and P. Pushpangadan, “Antioxidant approach to disease management and the role of “Rasayana” herbs of Ayurveda,” Journal of Ethnopharmacology, vol. 99, no. 2, pp. 165–178, 2005. View at: Publisher Site | Google Scholar
  5. K. A. Kirtikar and B. A. Basu, Indian Medicinal Plants, vol. 8, Periodical Expert’s Book Agency, New Delhi, India, 2nd edition, 2000.
  6. D. F. Austin, “Operculina turpethum (Convolvulaceae) as a medicinal plant in Asia,” Economic Botany, vol. 3, no. 6, pp. 265–2269, 1982. View at: Google Scholar
  7. K. Ragunathan and R. Mitra, Pharmacognosy of Indian Drugs, Central Council for Research in Ayurveda and Siddha, New Delhi, India, 1982.
  8. C. Asima and P. S. Chandra, The Treatise on Indian Medicinal Plants, vol. 4, Publication and Information Directorate, New Delhi, India, 1995.
  9. S. Jahan, N. Sujatha, and Neelam, “Role of Uttara Vasti with Trivrit and Lasuna oil in the management of primary dysmenorrhea,” Ayu, vol. 31, no. 2, pp. 228–2231, 2010. View at: Google Scholar
  10. S. Jain and V. K. Saxena, “Nonsaponifiable matter from the stem Operculina turpethum,” Acta Cienc Indica Chemistry, vol. 13, no. 3, pp. 171–1172, 1987. View at: Google Scholar
  11. R. P. Rastogi and B. N. Mehrotra, Compendium of Indian Medicinal Plants, vol. 2, CDRI Lucknow & NSIC, New Delhi, India, 1979.
  12. T. Schimming, K. Jenett-Siems, P. Mann et al., “Calystegines as chemotaxonomic markers in the Convolvulaceae,” Phytochemistry, vol. 66, no. 4, pp. 469–480, 2005. View at: Publisher Site | Google Scholar
  13. C. Anbuselvam, K. Vijayavel, and M. P. Balasubramanian, “Protective effect of Operculina turpethum against 7,12-dimethyl benz(a)anthracene induced oxidative stress with reference to breast cancer in experimental rats,” Chemico-Biological Interactions, vol. 168, no. 3, pp. 229–236, 2007. View at: Publisher Site | Google Scholar
  14. M. J. Alam, I. Alam, S. A. Sharmin, M. M. Rahman, M. Anisuzzaman, and M. F. Alam, “Micropropagation and antimicrobial activity of Operculina turpethum (syn. Ipomoea turpethum), an endangered medicinal plant,” Plant OMICS, vol. 3, no. 2, pp. 40–46, 2010. View at: Google Scholar
  15. P. Shankaraiah, R. C. Srinivasa, and P. Ravindra Babu, “Comparative antidiabetic activity of induced diabetic rats,” International Current Pharmaceutical Journal, vol. 1, no. 9, pp. 272–2278, 2012. View at: Google Scholar
  16. A. K. Khare, M. C. Srinivastava, J. P. Tewari, J. N. Puri, and S. Singh, “A preliminary study of anti-inflammatory activity of Ipomoea turpethum (Nisoth),” Indian Drugs, vol. 19, pp. 224–2226, 1982. View at: Google Scholar
  17. S. Suresh Kumar, C. Sujatha, J. Syamala, B. Nagasudha, and S. Mishra, “Protective effect of root extract of Operculina turpethum Linn. against paracetamol-induced hepatotoxicity in rats,” Indian Journal of Pharmaceutical Sciences, vol. 68, no. 1, pp. 32–35, 2006. View at: Google Scholar
  18. R. Ahmad, S. Ahmed, N. U. Khan, and A. U. Hasnain, “Operculina turpethum attenuates N-nitrosodimethylamine induced toxic liver injury and clastogenicity in rats,” Chemico-Biological Interactions, vol. 181, no. 2, pp. 145–153, 2009. View at: Publisher Site | Google Scholar
  19. R. K. Goel, S. Gupta, R. Shankar, and A. K. Sanyal, “Anti-ulcerogenic effect of banana powder (Musa sapientum var. paradisiaca) and its effect on mucosal resistance,” Journal of Ethnopharmacology, vol. 18, no. 1, pp. 33–44, 1986. View at: Google Scholar
  20. H. Shay, S. A. Komarov, S. S. Fels, D. Meranze, M. Gruenstein, and H. Siplet, “A simple method for the uniform production of gastric ulceration,” Gastroenterology, vol. 5, pp. 43–461, 1945. View at: Google Scholar
  21. H. Shay, D. C. Sun, and M. Gruenstein, “A quantitative method for measuring spontaneous gastric secretion in the rat,” Gastroenterology, vol. 26, no. 6, pp. 906–913, 1954. View at: Google Scholar
  22. S. Szabo, J. S. Trier, and A. Brown, “A quantitative method for assessing the extent of experimental gastric erosions and ulcers,” Journal of Pharmacological Methods, vol. 13, no. 1, pp. 59–66, 1985. View at: Publisher Site | Google Scholar
  23. F. J. Miñano, J. Serrano, J. Pascual, and M. Sancibrián, “Effects of GABA on gastric acid secretion and ulcer formation in rats,” Life Sciences, vol. 41, no. 13, pp. 1651–1658, 1987. View at: Google Scholar
  24. J. E. McGuigan, “Peptic ulcer and gastritis,” in Harrisons Principles of Internal Medicine, J. D. Wilson, E. Braunwald, K. J. Isselbacher et al., Eds., p. 1229, McGraw-Hill, New York, NY, USA, 12th edition, 1991. View at: Google Scholar
  25. R. K. Goel and S. K. Bhattacharya, “Gastroduodenal mucosal defence and mucosal protective agents,” Indian Journal of Experimental Biology, vol. 29, no. 8, pp. 701–714, 1991. View at: Google Scholar
  26. R. S. Deoda, D. Kumar, and S. S. Bhujbal, “Gastroprotective effect of Rubia cordifolia linn. on aspirin plus pylorus-ligated ulcer,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 541624, 5 pages, 2011. View at: Publisher Site | Google Scholar
  27. P. B. Hawk, Hawk's Physiological Chemistry, Edited by B. L. Oster, McGraw-Hill, New York, NY, USA, 14th edition, 1965.
  28. Y. Qian, J. M. Si, J. G. Wu et al., “Effect of mucosal protective on the quality of gastric ulcer healing,” Journal of Zhejiang University, vol. 36, no. 1, pp. 71–77, 2007. View at: Google Scholar
  29. B. E. Lukie and G. G. Forstner, “Synthesis of intestinal clycoproteins inhibition of [1-14C]glucosamine incorporation by sodium salicylate in vitro,” Biochimica et Biophysica Acta, vol. 273, no. 2, pp. 380–388, 1972. View at: Google Scholar
  30. N. Vasudeva, P. Sethi, S. K. Sharma, S. Kumar, and S. Sharma, “Antiulcer potential of the ethanolic extract of Aerva persica Merrill root in rats,” Journal of Acupuncture Meridian Studies, vol. 5, no. 2, pp. 80–86, 2012. View at: Google Scholar
  31. E. Sanmugapriya and S. Venkataraman, “Antiulcerogenic potential of Strychnos potatorum Linn seeds on Aspirin plus pyloric ligation-induced ulcers in experimental rats,” Phytomedicine, vol. 14, no. 5, pp. 360–365, 2007. View at: Publisher Site | Google Scholar
  32. A. H. M. Thippeswamy, M. Sajjan, M. B. Palkar, B. C. Koti, and A. H. M. Viswanathaswamy, “Comparative study of proton pump inhibitors on dexamethasone plus pylorus ligation induced ulcer model in rats,” Indian Journal of Pharmaceutical Sciences, vol. 72, no. 3, pp. 367–371, 2010. View at: Publisher Site | Google Scholar
  33. S. Jaikumar, S. Ramaswamy, B. R. Asokan, T. Mohan, and M. Gnanavel, “Anti ulcer activity of methanolic extract of Jatropha curcas (Linn.) on Aspirin-induced gastric lesions in wistar strain rats,” Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 1, no. 4, pp. 886–897, 2010. View at: Google Scholar
  34. P. Singh and D. Guha, “Aegle marmelos enhances gastric mucosal protection: relevance for NSAIDS-induced gastric mucosal injury,” Al Ameen Journal of Medical Science, vol. 5, no. 3, pp. 243–2255, 2012. View at: Google Scholar
  35. A. K. Sanyal, P. K. Mitra, and R. K. Goel, “A modified method to estimate dissolved mucosubstances in gastric juice,” Indian Journal of Experimental Biology, vol. 21, no. 2, pp. 78–80, 1983. View at: Google Scholar
  36. R. K. Goel, M. Chakravarty, W. Rahamatalla Abbas, K. P. Singh, and S. K. Bhattacharya, “Effect of piracetam, a nootropic agent, on experimental gastric ulcers in rat,” Indian Journal of Experimental Biology, vol. 28, no. 4, pp. 337–340, 1990. View at: Google Scholar
  37. M. G. Repetto and S. F. Llesuy, “Antioxidant properties of natural compounds used in popular medicine for gastric ulcers,” Brazilian Journal of Medical and Biological Research, vol. 35, no. 5, pp. 523–534, 2002. View at: Google Scholar
  38. M. O. Sofidiya, L. Agufobi, A. J. Akindele, J. A. Olowe, and O. B. Familoni, “Effect of Flabellaria paniculata Cav. extracts on gastric ulcer in rats,” BMC Complementary and Alternative Medicine, vol. 2, no. 12, p. 168, 2012. View at: Google Scholar
  39. J. K. Adesanwo, O. Ekundayo, F. S. Oluwole, O. A. Olajide, A. J. J. Van Den Berge, and J. A. Findlay, “The effect of Tetracera potatoria and its constituent betulinic acid on gastric acid secretion and experimentally-induced gastric ulceration,” Nigerian Journal of Physiological Sciences, vol. 18, no. 1-2, pp. 21–26, 2003. View at: Google Scholar
  40. F. S. Oluwole, J. A. Ayo, B. O. Omolaso, B. O. Emikpe, and J. K. Adesanwo, “Methanolic extract of Tetracera potatoria, an antiulcer agent increases gastric mucus secretion and endogenous antioxidants,” Nigerian Journal of Physiological Sciences, vol. 23, no. 1-2, pp. 79–83, 2008. View at: Google Scholar
  41. C. Onwuchekwa and F. S. Oluwole, “Anti-gastric ulcer and Anti-inflammatory properties of betulinic acid in male albino rats,” Science World Journal, vol. 5, no. 4, pp. 15–117, 2010. View at: Google Scholar
  42. D. Palanimuthu, N. Baskaran, S. Silvan, D. Rajasekaran, and S. Manoharan, “Lupeol, a bioactive triterpene, prevents tumor formation during 7, 12-dimethylbenz (a) anthracene induced oral carcinogenesis,” Pathology and Oncology Research, vol. 18, no. 4, pp. 1029–1037, 2012. View at: Google Scholar
  43. A. Kumari and P. Kakkar, “Lupeol protects against acetaminophen-induced oxidative stress and cell death in rat primary hepatocytes,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1781–11789, 2012. View at: Google Scholar
  44. M. M. Malini, M. Lenin, and P. Varalakshmi, “Protective effect of triterpenes on calcium oxalate crystal-induced peroxidative changes in experimental urolithiasis,” Pharmacological Research, vol. 41, no. 4, pp. 413–418, 2000. View at: Publisher Site | Google Scholar
  45. S. S. Sakat, P. Tupe, and A. Juvekar, “Gastroprotective effect of Oxalis corniculata (whole plant) on experimentally induced gastric ulceration in wistar rats,” Indian Journal of Pharmaceutical Sciences, vol. 74, no. 1, pp. 48–53, 2012. View at: Google Scholar
  46. V. C. Devaraj and B. G. Krishna, “Gastric antisecretory and cytoprotective effects of leaf extracts of Amaranthus tricolor Linn. in rats,” Zhong Xi Yi Jie He Xue Bao, vol. 9, no. 9, pp. 1031–11038, 2011. View at: Google Scholar

Copyright © 2013 Vidya Ignatius et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.